Changes in Cervical Cytology Results and Human Papillomavirus Types Among Persons Screened for Cervical Cancer, 2007 and 2015–2017

1National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA

2Synergy America, Inc, Duluth, GA

3Center for Health Research, Kaiser Permanente Northwest, Portland, OR

4Kaiser Permanente Vaccine Study Center, Oakland, CA

5National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA

6Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA

Reprint requests to: Rayleen Lewis, MPH, Synergy America, Inc, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, MS H24-5 Atlanta, GA. E-mail: [email protected]

A.L.N. has received research funding from Pfizer, Takeda, MedImmune, and Merck for unrelated studies. N.P.K. has received research funding from Merck, GlaxoSmithKline, Sanofi Pasteur, Novartis, MedImmune, Pfizer, and Protein Sciences (now Sanofi Pasteur) for unrelated studies. S.W. has received research funding from GlaxoSmithKline for an unrelated study. The other authors have declared they have no conflicts of interest.

This work was funded by the Centers for Disease Control and Prevention.

The study was study was approved at the Kaiser Permanente Northwest and Kaiser Permanente Northern California, determination of nonengagement at the Centers for Disease Control and Prevention.

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

留言 (0)

沒有登入
gif